Cassava Sciences, Inc.
SAVA
$2.18
$0.041.87%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -44.22M | -23.40M | -27.60M | -27.94M | 6.16M |
Total Depreciation and Amortization | 218.00K | 220.00K | 260.00K | 259.00K | 302.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4.58M | 5.23M | 5.74M | 5.61M | -62.54M |
Change in Net Operating Assets | 34.48M | 6.62M | -39.67M | 3.78M | 37.84M |
Cash from Operations | -4.95M | -11.34M | -61.27M | -18.30M | -18.24M |
Capital Expenditure | -- | -- | -57.00K | -17.00K | -29.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -57.00K | -17.00K | -29.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00 | 90.00K | 918.00K | 0.00 | 101.39M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 0.00 | 90.00K | 918.00K | 0.00 | 101.39M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -4.95M | -11.25M | -60.40M | -18.31M | 83.12M |